|
PLK1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.57442980664291E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.55529999568938E-08 |
| Normal-vs-Stage2 |
1.144660E-03 |
| Normal-vs-Stage3 |
3.62469999570791E-08 |
| Normal-vs-Stage4 |
3.98199999973592E-07 |
| Stage1-vs-Stage2 |
4.368600E-01 |
| Stage1-vs-Stage3 |
4.561800E-03 |
| Stage1-vs-Stage4 |
2.358500E-04 |
| Stage2-vs-Stage3 |
2.189600E-01 |
| Stage2-vs-Stage4 |
3.019000E-03 |
| Stage3-vs-Stage4 |
2.593600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.13851159003298E-12 |
| Normal-vs-AfricanAmerican |
2.002300E-03 |
| Normal-vs-Asian |
1.784250E-01 |
| Caucasian-vs-AfricanAmerican |
2.145500E-02 |
| Caucasian-vs-Asian |
4.494000E-01 |
| AfricanAmerican-vs-Asian |
3.127200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.26942942005826E-12 |
| Normal-vs-Female |
1.80770000079988E-08 |
| Male-vs-Female |
5.374300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.197610E-02 |
| Normal-vs-Age(41-60Yrs) |
1.4020999916653E-09 |
| Normal-vs-Age(61-80Yrs) |
5.55870016683002E-10 |
| Normal-vs-Age(81-100Yrs) |
6.457500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.866180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.067000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.800300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.470000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.696770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.884000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.808200E-02 |
| Normal-vs-Grade 2 |
2.12599999827034E-08 |
| Normal-vs-Grade 3 |
2.24489982159071E-10 |
| Normal-vs-Grade 4 |
7.22699999955445E-07 |
| Grade 1-vs-Grade 2 |
6.200900E-03 |
| Grade 1-vs-Grade 3 |
2.72670000001085E-06 |
| Grade 1-vs-Grade 4 |
1.95939999999561E-05 |
| Grade 2-vs-Grade 3 |
1.997740E-03 |
| Grade 2-vs-Grade 4 |
1.755110E-04 |
| Grade 3-vs-Grade 4 |
3.578900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.65170000000692E-05 |
| Normal-vs-ccB subtype |
1.08469999648975E-09 |
| ccA subtype-vs-ccB subtype |
3.35200000001201E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.25369944928389E-10 |
| Normal-vs-N1 |
1.736190E-03 |
| N0-vs-N1 |
1.291930E-02 |
|
|
